Sharda Cropchem reported strong Q3 and 9M FY26 financial results.

Q3 revenue grew 39% to ₹1,289 Cr, with profit after tax (PAT) surging 366% to ₹145 Cr.

For 9M FY26, revenue increased 29% to ₹3,203 Cr and PAT jumped 259% to ₹362 Cr.

The Agrochemicals segment led growth, with Europe as a key contributor, seeing a 123% rise in Q3. Gross margins improved to 34.9% in Q3 and 35.0% in 9M. EBITDA for Q3 was ₹246 Cr (+59%). The company's strategy focuses on building a sales force for a 'factory-to-farmer' approach, expanding global distribution, and continuously investing in new product registrations.

Management expects gross margins to remain stable for FY26, with Europe and LATAM driving future volume growth.

Recent developments include ₹399 Cr CAPEX in 9M FY26 and a 48-day reduction in working capital.

Sharda aims to leverage its IP-driven asset-light model in over 80 countries.